This article first appeared on GuruFocus.

Privia Health Group Inc (NASDAQ:PRVA) is set to release its Q3 2025 earnings on Nov 6, 2025. The consensus estimate for Q3 2025 revenue is $753.45 million, and the earnings are expected to come in at $0.05 per share. The full year 2025's revenue is expected to be $3.35 billion and the earnings are expected to be $0.16 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 5 Warning Sign with PRVA.

Is PRVA fairly valued? Test your thesis with our free DCF calculator.

Revenue estimates for Privia Health Group Inc (NASDAQ:PRVA) have increased from $3.24 billion to $3.35 billion for the full year 2025. However, for 2026, they have declined from $3.58 billion to $3.39 billion over the past 90 days. Earnings estimates have declined from $0.21 per share to $0.16 per share for the full year 2025, and from $0.33 per share to $0.32 per share for 2026 over the past 90 days.

In the previous quarter ending on June 30, 2025, Privia Health Group Inc's (NASDAQ:PRVA) actual revenue was $862.90 million, which beat analysts' revenue expectations of $800.10 million by 7.85%. Privia Health Group Inc's (NASDAQ:PRVA) actual earnings were $0.02 per share, which missed analysts' earnings expectations of $0.05 per share by 60%. After releasing the results, Privia Health Group Inc (NASDAQ:PRVA) was down by 1.37% in one day.

Based on the one-year price targets offered by 18 analysts, the average target price for Privia Health Group Inc (NASDAQ:PRVA) is $31.56 with a high estimate of $45.00 and a low estimate of $22.00. The average target implies an upside of 27.81% from the current price of $24.69.

Based on GuruFocus estimates, the estimated GF Value for Privia Health Group Inc (NASDAQ:PRVA) in one year is $45.59, suggesting an upside of 84.65% from the current price of $24.69.

Based on the consensus recommendation from 20 brokerage firms, Privia Health Group Inc's (NASDAQ:PRVA) average brokerage recommendation is currently 1.8, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.